(CercleFinance.com) – Siemens Healthineers is selling nearly 2% in Frankfurt while UBS announced this morning to reduce its target price on the stock, from 59 to 57 euros, while maintaining its ‘buy’ advice on the value.
‘The stock price decline provides an interesting new entry point, but this time investors are focused on the execution of Siemens Healthineers, not market momentum’, broker says day after quarterly release .
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
